Men’s Health
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14
12/12/2019 - STI challenge for PrEP
Programmes providing pre-exposure prophylaxis to prevent HIV infection need to spend time on patients' overall sexual health, according to a World Health Organisation study. More
03/12/2019 - Olaparib promising for advanced prostate cancer
A gene-targeted medicine, for breast and ovarian cancer, shows promise for some men with advanced prostate cancer, the results of a new clinical trial have shown. More
29/11/2019 - Immunotherapy helps prostate cancer 'super responders'
So-called prostate cancer “super responders” could live for two years or longer on immunotherapy, a major new clinical trial has revealed. More
22/11/2019 - Statins may protect against lethal prostate disease
Statins may help protect men from the most lethal forms of prostate cancer, according to Irish researchers. More
13/11/2019 - Male cancer survivors may need hormone boost
Young male cancer survivors may benefit from treatment with replacement testosterone, British experts have reported. More
01/11/2019 - Two hormones key to prostate cancer risk
Men have an increased risk of developing prostate cancer if their blood has high levels of free testosterone and a growth hormone, a conference hears today. More
30/09/2019 - Prostate surgery sufficient - conference hears
Men who have surgery for prostate cancer do not need post-operative radiotherapy, according to the findings of a major trial. More
23/09/2019 - Prostate cancer research breakthrough
British scientists say they have made key breakthroughs in the search for new drugs effective against prostate cancer. More
17/09/2019 - BRCA2 gene fault link to prostate cancer risk
Men with the BRCA2 gene fault have a higher risk of developing prostate cancer and would benefit from prostate specific antigen (PSA) testing to help detect the disease earlier, according to new research. More
21/08/2019 - Symptoms not cause of MI treatment gender discrepancies
Women and men display the same symptoms during myocardial infarction, according to a study published today aimed at explaining gender differences in treatment. More
23/07/2019 - DNA test plan to improve prostate targeted nuclear medicine
DNA testing could help identify me who will benefit from targeted nuclear medicine for the treatment of prostate cancer, researchers report today. More
19/06/2019 - Yoghurt may help prevent bowel cancer
Men who eat yoghurt at least twice a week appear to have a reduced risk of developing adenomas in the bowel, researchers report today. More
29/05/2019 - Gender response to chemotherapy investigated
Women given chemotherapy for oesophagogastric cancer had better survival than men – but experienced worse side effects, a UK-based research project has found. More
15/05/2019 - Backing for radiotherapy side-effect gel
Hospitals are to be encouraged to use an injectable gel to reduce the side-effects of prostate cancer radiotherapy, it has been announced. More
07/05/2019 - Retinoblastoma gene points to prostate problems
A gene linked to eye cancer may also indicate a man's risk of developing aggressive forms of prostate cancer, British researchers reported last night. More
05/04/2019 - Health care access key to life expectancy - WHO
Access to health care globally is a key factor in gaps in life expectancy, the World Health Organisation reported last night. More
27/03/2019 - Prostate cancer protein's "surprising" behaviour
Researchers looking at the behaviour of prostate cancer cells have made a surprising discovery. More
18/03/2019 - Coffee compounds could inhibit prostate cancer - lab study
Compounds found in coffee could inhibit prostate cancer, a European conference is to hear today. More
13/03/2019 - On-line aid helps men make prostate choices
An on-line calculator can give patients with prostate cancer a highly accurate prognosis – enabling them to choose whether to undergo treatment or not, British researchers announced last night. More
11/03/2019 - PARP inhibitors could boost immunotherapy
PARP inhibitors could be combined effectively with immunotherapies to destroy tumours in several kinds of cancer, according to a joint Anglo-French project. More
Printer friendly page